MMCAP International’s BiomX Inc. Warrants to purchase one-half of a share of Common Stock PHGE.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,431,188
Closed -$27.6K 259
2023
Q1
$27.6K Hold
1,431,188
0.01% 167
2022
Q4
$28.6K Hold
1,431,188
﹤0.01% 250
2022
Q3
$54K Hold
1,431,188
﹤0.01% 295
2022
Q2
$57K Hold
1,431,188
﹤0.01% 316
2022
Q1
$188K Hold
1,431,188
0.01% 329
2021
Q4
$157K Hold
1,431,188
0.01% 358
2021
Q3
$472K Hold
1,431,188
0.03% 262
2021
Q2
$859K Hold
1,431,188
0.04% 208
2021
Q1
$930K Hold
1,431,188
0.09% 198
2020
Q4
$1.15M Hold
1,431,188
0.22% 74
2020
Q3
$1.02M Hold
1,431,188
0.26% 43
2020
Q2
$686K Hold
1,431,188
0.25% 29
2020
Q1
$859K Buy
1,431,188
+856,930
+149% +$738K 0.91% 15
2019
Q4
$270K Buy
+574,258
New +$358K 0.09% 28

Other funds holding PHGE.WS

MMCAP International's PHGE.WS Position: Q2 2023 in Review

MMCAP International sold out of BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) in Q2 2023, closing a stake of 1,431,188 shares — an estimated $27.6K sold.

MMCAP International first reported a position in PHGE.WS in Q4 2019 and held it in 14 quarters. The position peaked at $1.15M in Q4 2020. 1 fund tracked by Wall St. Rank holds PHGE.WS as of Q2 2023.

  • MMCAP International reported no remaining BiomX Inc. Warrants to purchase one-half of a share of Common Stock position as of Q2 2023 after selling out during the quarter.
  • MMCAP International sold 1,431,188 BiomX Inc. Warrants to purchase one-half of a share of Common Stock shares in Q2 2023, an estimated $27.6K.
  • MMCAP International first reported a position in BiomX Inc. Warrants to purchase one-half of a share of Common Stock in Q4 2019 and held it in 14 quarters.
  • MMCAP International's BiomX Inc. Warrants to purchase one-half of a share of Common Stock position peaked at $1.15M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BiomX Inc. Warrants to purchase one-half of a share of Common Stock as of Q2 2023.

Based on MMCAP International's 13F filing for Q2 2023, filed 14 Aug 2023.